Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

STARDUST POWER INC. (SDST)

  • Business News
  • June 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Stardust Power Advances Execution Readiness at Muskogee Lithium Refinery

Market reaction Comment Full text

COGNITION THERAPEUTICS INC (CGTX)

  • Business News
  • June 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045

Market reaction Comment Full text

SOLANA CO (HSDT)

  • Business News
  • June 16, 2026, 11:30 UTC
  • 1
  • 1 comments

Solana Company Board Unanimously Rejects Unsolicited Forward Industries Proposal

Market reaction Comment Full text

ATLANTIC UNION BANKSHARES CORP (AUB)

  • Business News
  • June 16, 2026, 11:27 UTC
  • 1
  • 1 comments

Atlantic Union Bank Selects Spiral to Boost Customer Savings and Community Impact Through Everyday Banking

Market reaction Comment Full text

NATIONAL PRESTO INDUSTRIES INC (NPK)

  • Business News
  • June 16, 2026, 11:24 UTC
  • 1
  • 1 comments

Magnes Rare Earths Reports 10 m From Surface at 0.97% TREO at Minas Americas Rare Earth Project

Market reaction Comment Full text

Nephros Inc (NEPH)

  • Business News
  • June 16, 2026, 11:14 UTC
  • 1
  • 1 comments

Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water

Market reaction Comment Full text

ERICSSON LM TELEPHONE CO (ERIC)

  • Business News
  • June 16, 2026, 11:13 UTC
  • 1
  • 1 comments

Per Narvinger appointed new President and CEO of Ericsson as Börje Ekholm steps down

Market reaction Comment Full text

SIGNATURE DEVICES, INC. (SDVI)

  • Business News
  • June 16, 2026, 11:06 UTC
  • 3
  • 1 comments

Net Asset Value(s)

Market reaction Comment Full text

Edgewise Therapeutics Inc (EWTX)

  • Business News
  • June 16, 2026, 11:01 UTC
  • 3
  • 1 comments

Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

Market reaction Comment Full text

INVIVYD, INC. (IVVD)

  • Business News
  • June 16, 2026, 11:01 UTC
  • 3
  • 1 comments

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Market reaction Comment Full text
  • Previous
  • 426
  • 427
  • 428
  • 429
  • 430
  • Next

Search

News categories

  • Technical Exchange News(13348)
  • Event(6229)
  • SEC News(340634)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(188730)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin